Search Results Search Sort by RelevanceMost Recent Viewpoint May 2022 Reimagining Roles of Dietary Supplements in Psychiatric Care Katherine Wu, MD and Erik Messamore, MD, PhD Government-supported review and safety monitoring is needed for dietary supplements’ use in the care of patients with mental illness. AMA J Ethics. 2022;24(5):E437-442. doi: 10.1001/amajethics.2022.437. Podcast May 2022 Author Interview: “Reimagining Roles of Dietary Supplements in Psychiatric Care” Dr Katherine Wu joins Ethics Talk to discuss her article, coauthored with Dr Erik Messamore: “Reimagining Roles of Dietary Supplements in Psychiatric Care.” Case and Commentary Aug 2007 Western Medicine's Diagnostic Labels Are Not Universal Andres Sciolla, MD Virtual Mentor. 2007;9(8):527-531. doi: 10.1001/virtualmentor.2007.9.8.ccas1-0708. State of the Art and Science Jul 2008 Managing Somatization Disorder Robert McCarron, DO Virtual Mentor. 2008;10(7):447-452. doi: 10.1001/virtualmentor.2008.10.7.cprl1-0807. Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.
Viewpoint May 2022 Reimagining Roles of Dietary Supplements in Psychiatric Care Katherine Wu, MD and Erik Messamore, MD, PhD Government-supported review and safety monitoring is needed for dietary supplements’ use in the care of patients with mental illness. AMA J Ethics. 2022;24(5):E437-442. doi: 10.1001/amajethics.2022.437.
Podcast May 2022 Author Interview: “Reimagining Roles of Dietary Supplements in Psychiatric Care” Dr Katherine Wu joins Ethics Talk to discuss her article, coauthored with Dr Erik Messamore: “Reimagining Roles of Dietary Supplements in Psychiatric Care.”
Case and Commentary Aug 2007 Western Medicine's Diagnostic Labels Are Not Universal Andres Sciolla, MD Virtual Mentor. 2007;9(8):527-531. doi: 10.1001/virtualmentor.2007.9.8.ccas1-0708.
State of the Art and Science Jul 2008 Managing Somatization Disorder Robert McCarron, DO Virtual Mentor. 2008;10(7):447-452. doi: 10.1001/virtualmentor.2008.10.7.cprl1-0807.
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.